3.04
-0.11(-3.49%)
Currency In USD
| Previous Close | 3.15 |
| Open | 3.13 |
| Day High | 3.26 |
| Day Low | 2.98 |
| 52-Week High | 15.05 |
| 52-Week Low | 2.92 |
| Volume | 444,506 |
| Average Volume | 425,065 |
| Market Cap | 121.46M |
| PE | -1 |
| EPS | -3.04 |
| Moving Average 50 Days | 4.25 |
| Moving Average 200 Days | 6.85 |
| Change | -0.11 |
If you invested $1000 in Solid Biosciences Inc. (SLDB) since IPO date, it would be worth $8.96 as of February 04, 2025 at a share price of $3.04. Whereas If you bought $1000 worth of Solid Biosciences Inc. (SLDB) shares 5 years ago, it would be worth $58.74 as of February 04, 2025 at a share price of $3.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
GlobeNewswire Inc.
Jan 21, 2025 1:30 PM GMT
- Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation - CHARLESTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences com
Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines
GlobeNewswire Inc.
Jan 15, 2025 9:05 PM GMT
- Duchenne: Dosed four patients in INSPIRE DUCHENNE clinical trial; SGT-003 has been well tolerated in all patients with no SAEs observed; initial three patient data expected Q1 2025 - - FA: First-in-human clinical study of SGT-212 utilizing a dual r
Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 08, 2025 9:05 PM GMT
CHARLESTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that Bo C